Table 1.
TLS occurrence per amount of tumor burden
Tumor burden
.
Tumor burden at start of venetoclax, n (%)
.
Developed laboratory TLS, n (%)
.
Low
8 (24)
3 (38)
Medium
20 (61)
11 (55)
High
5 (15)
3 (60)
Tumor burden
.
Tumor burden at start of venetoclax, n (%)
.
Developed laboratory TLS, n (%)
.
Low
8 (24)
3 (38)
Medium
20 (61)
11 (55)
High
5 (15)
3 (60)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal